128 related articles for article (PubMed ID: 30409896)
21. Treatment of acute myeloid leukemia M3 in a patient with Crohn's disease.
Harewood G; Markovic S
Cancer Invest; 2000; 18(1):98. PubMed ID: 10701373
[No Abstract] [Full Text] [Related]
22. Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia.
Kim DY; Lee JH; Lee JH; Kim SD; Lim SN; Choi Y; Lee YS; Kang YA; Seol M; Jeon M; Kim JY; Lee KH; Lee YJ; Lee KH
Leuk Res; 2011 Feb; 35(2):152-8. PubMed ID: 20554322
[TBL] [Abstract][Full Text] [Related]
23. Update on the management of pediatric acute promyelocytic leukemia.
Ribeiro R
Clin Adv Hematol Oncol; 2006 Apr; 4(4):263-5. PubMed ID: 16728936
[No Abstract] [Full Text] [Related]
24. Combined therapy with all-trans-retinoic acid and high-dose chemotherapy in patients with hyperleukocytic acute promyelocytic leukemia and severe visceral hemorrhage.
Dombret H; Sutton L; Duarte M; Daniel MT; Leblond V; Castaigne S; Degos L
Leukemia; 1992 Dec; 6(12):1237-42. PubMed ID: 1453767
[TBL] [Abstract][Full Text] [Related]
25. Coagulation patterns of disseminated intravascular coagulation in acute promyelocytic leukemia.
Higuchi T; Shimizu T; Mori H; Niikura H; Omine M
Hematol Oncol; 1997 Nov; 15(4):209-17. PubMed ID: 9722892
[TBL] [Abstract][Full Text] [Related]
26. Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction.
Hambley BC; Norsworthy KJ; Jasem J; Zimmerman JW; Shenderov E; Webster JA; Showel MM; Gondek LP; Dalton WB; Prince G; Gladstone DE; Streiff MB; Pratz KW; Gojo I; Ghiaur G; Levis MJ; Smith BD; DeZern AE
Leuk Res; 2019 Aug; 83():106174. PubMed ID: 31255938
[No Abstract] [Full Text] [Related]
27. Thrombo-hemorrhagic deaths in acute promyelocytic leukemia.
Breccia M; Lo Coco F
Thromb Res; 2014 May; 133 Suppl 2():S112-6. PubMed ID: 24862130
[TBL] [Abstract][Full Text] [Related]
28. Acute promyelocytic leukemia: impact of hemorrhagic complications on response to induction chemotherapy and survival.
Humphries JE; Hess CE; Stewart FM
South Med J; 1990 Oct; 83(10):1157-61. PubMed ID: 2218655
[TBL] [Abstract][Full Text] [Related]
29. Ultrastructural observations on a variant of acute promyelocytic leukemia.
Djaldetti M; Gardyn J; Maran R; Floru S; Mittelman M
Leuk Lymphoma; 1993 Mar; 9(4-5):427-31. PubMed ID: 8348079
[TBL] [Abstract][Full Text] [Related]
30. [Macrocheilia revealing an acute promyelocytic leukemia].
Albisetti C; Khonsari RH; Goudot P; Razouk O
Rev Stomatol Chir Maxillofac Chir Orale; 2016 Jun; 117(3):161-3. PubMed ID: 27117683
[TBL] [Abstract][Full Text] [Related]
31. Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients.
Dally N; Hoffman R; Haddad N; Sarig G; Rowe JM; Brenner B
Thromb Res; 2005; 116(2):109-14. PubMed ID: 15907524
[TBL] [Abstract][Full Text] [Related]
32. All-trans retinoic acid in the treatment of acute promyelocytic leukaemia.
White KL; Wiley JS; Frost T; McKendrick JJ; Hermann RP; Seldon M; Enno A; Bell R; Bunce I; Taylor K
Aust N Z J Med; 1992 Oct; 22(5):449-54. PubMed ID: 1445034
[TBL] [Abstract][Full Text] [Related]
33. A 56-year-old man with acute promyelocytic leukemia and pulmonary infiltrates.
Weir DC; Fung JY; Braman SS
Chest; 2014 Sep; 146(3):e88-e91. PubMed ID: 25180749
[TBL] [Abstract][Full Text] [Related]
34. Acute promyelocytic leukaemia: looking through 'gums'.
Jain A; Lad D; Malhotra P; Bommannan K
BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27903578
[No Abstract] [Full Text] [Related]
35. Predictive factors of fatal bleeding in acute promyelocytic leukemia.
Mantha S; Tallman MS; Devlin SM; Soff GA
Thromb Res; 2018 Apr; 164 Suppl 1():S98-S102. PubMed ID: 29703492
[TBL] [Abstract][Full Text] [Related]
36. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia.
Chen SJ; Zelent A; Tong JH; Yu HQ; Wang ZY; Derré J; Berger R; Waxman S; Chen Z
J Clin Invest; 1993 May; 91(5):2260-7. PubMed ID: 8387545
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow necrosis following ALL-trans retinoic acid therapy for acute promyelocytic leukaemia.
Dreosti LM; Bezwoda W; Gunter K
Leuk Lymphoma; 1994 Apr; 13(3-4):353-6. PubMed ID: 8049655
[TBL] [Abstract][Full Text] [Related]
38. Bone marrow necrosis obscuring the diagnosis of acute promyelocytic leukemia.
Wisecarver J; Harrington D
Hematol Pathol; 1988; 2(1):51-4. PubMed ID: 3235382
[TBL] [Abstract][Full Text] [Related]
39. M3-variant of acute promyelocytic leukaemia. A case report in a Malay boy.
Jazilah W; Ariffin W; Jackson N
Med J Malaysia; 1995 Mar; 50(1):105-7. PubMed ID: 7752961
[TBL] [Abstract][Full Text] [Related]
40. Automated differential counts in acute promyelocytic leukemia patients may be misleading.
Kapelushnik J; Kafka M; Moser A; Yermiahu T
Med Pediatr Oncol; 2002 Apr; 38(4):269-70. PubMed ID: 11920794
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
